In Brief: Roche v. Organon Teknika
This article was originally published in The Gray Sheet
Executive Summary
Roche v. Organon Teknika: Roche files suit against Organon Teknika alleging that Teknika's NASBA gene amplification technology used in two HIV tests available in Europe infringes Roche's European patent for polymerase chain reaction amplification technology. The suit, filed in the District Court in The Hague, the Netherlands, seeks to prohibit Teknika from marketing the quantitative and qualitative HIV test kits in Europe, as well as any future assays using the NASBA technology. Teknika "has carefully studied and evaluated" Roche's PCR patent "and has concluded that [the patent] bears no relevance to the NASBA tests," the company says. Teknika, which has "a number" of patents for NASBA, is currently developing 10 additional assays based on the technology, including a test for tuberculosis...
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.